The cDNA for a c-myc intron 1 binding protein 1 (MIBP1) in the rat was Isolated from \gt11 and XZAPII cDNA libraries. Sequencing of the cDNA clones revealed a long ORF which encoded a putative protein of 2437 amlno acid residues. This protein has two widely separated zinc finger regions, each of which carries C2H2 motifs. When expressed in E.coll as a fusion protein, part of the MIBP1 showed sequencespecific binding to the target sequence, I.e., a 9-bp sequence in the rat c-myc intron 1. MIBP1 is most likely the rat counterpart of human MHC binding proteln-2 (MBP-2/HIV-EP2), based on the 86% similarity in nucleotlde sequence and 93% similarity in amino acid sequence. Northern blotting revealed a high level of MIBP1 mRNA in the brain.
INTRODUCTION
c-myc is known to be involved in oncogenesis and cell immortalization (1, 2) . The c-myc protein is a sequence-specific DNA binding protein, which acts as a hetero-oligomer with Max, and is thought to regulate transcription (3) .
c-myc is a typical immediate early gene, i.e., its expression is rapidly and transiendy elevated just after cells are exposed to growth stimuli (4, 5) . The level of c-myc mRNA seems to be controlled by three separate processes; initiation of transcription, blockage of transcript elongation and mRNA degradation. Early studies suggested that rij-acting regulatory elements were present in the exon 1 -intron 1 region of the gene, which might be the binding site for transcriptional factors (6) . Elongation of c-myc transcript is blocked at the exon 1 -intron 1 region and this blockage of transcription seems to be a major mode of regulation of this gene during cell differentiation (7) , although the precise mechanism of this transcription-blockage is unknown. Some protein may bind to a sequence in this region, and signal RNA polymerase II either stop or proceed.
Other findings also suggest that the intron 1 region is involved in regulation of expression of the gene. In some Burkitt lymphomas and plasmacytomas, breakpoints have been found within exon 1 or intron 1. Disruptions or point mutations in this region in Burkitt lymphomas (8, 9) seem to activate a cryptic promoter in intron 1 (10, 11) , resulting in deregulation or overexpression of c-myc (12, 13) . All of these observations suggest that the exon 1 -intron 1 region of c-myc is important in the regulation of its expression. In light of these facts, protein binding sites have been sought in this region (the 5'-portion of intron 1) and several sites were identified which may regulate expresison of the gene (14, 15 and our unpublished data).
c-myc expression varies among tissues. Its mRNA level is very low in normal liver, but is increased in hepatocarcinoma and regenerating liver of the rat (5, 16, 17) . These observations prompted us to look for factors that negatively regulate expression of c-myc in normal liver. We have detected several proteinbinding sites in the 5'-region of intron 1 of c-myc using liver nuclear extract of rat by gel shift, DNase I footprinting and methylation interference (data not shown) analyses. In an effort to characterize c-myc regulation by the proteins that bind to these sites, we isolated a cDNA clone which coded for one of these proteins by the southwestern method. cDNA clones which covered a complete coding region of this protein were obtained by further screening.
MATERIALS AND METHODS
Gel shift assay and DNase I footprinting using nuclear extract Nuclear extract from liver of 5-week-old Sprague-Dawley rats was prepared as described by Gorski et id. (18) . Rats were sacrificed under ether anesthesia by exsanguination from neck. Probe, specific competitor (nucleotides 458 to 580, nucleotide of the major transcription initiation, P2, numbered 1; see ref. 19 ) and non-specific, unrelated competitor (-532 to -453) DNA's were prepared by PCR using template plasmid pMP4
•To whom correspondence should be addressed which carried upstream exon 1 and part of intron 1 of rat c-myc (19) . One of the primers was labeled at the 5'-end with 32 P by T 4 polynucleotide kinase and T 32 P-ATP (16) , and used to amplify the target sequence to obtain the probe. Binding reactions were carried out for 15 min on ice in 20 ml of 15 mM HEPES-KOH, pH 7.6, 50 mM KC1, 0.05 mM EDTA, 12 % glycerol, 1 mM DTT, 1 mM MgCl 2 , 0.1 mM phenylmethylsulfonylfluoride (PMSF, Sigma) and 2 mg of poly(dA-dT):poly(dA-dT) (Pharmacia) (18) . The complexes formed were analyzed either by gel electrophoresis in 0.25 xTBE or by DNase I footprinting as described by Lichtsteiner et al. (20) .
Southwestern and Southern screening
A Xgtl 1 liver cDNA library of Sprague-Dawley rat (Clonetech) was used for Southwestern screening (21) . Concatemer of one of the protein binding sites in intron 1 (TAGTTGGGGTA-GGCCGGGGC; nucleotides 510 to 529) was used as a probe.
A XZAPII brain cDNA library of Sprague-Dawley rat (Stratagene) was used for further screening to obtain longer cDNA by Southern hybridization. Inserts of the XZAPII clones were converted to plasmids by methods suggested by the supplier. Appropriate DNA segments were excised from plasmids, labeled by the random priming method (Multiprime DNA Labeling System, Amersham) and used as probes for hybridization. Standard methods were followed for other procedures of cloning and DNA analysis (22) .
Sequencing
Nucleotide sequences were determined by an automated DNA sequencer (A.L.F. DNA sequencer, Pharmacia). A Delta-Taq DNA sequencing kit (USB), CucumVent DNA sequencing kit (New England Bio-Labs) or AutoRead sequencing kit (Pharmacia) was used for sequencing reactions. 5'-Fluorescein-labeled primers were made with a DNA synthesizer with FluorePrime (Pharmacia) and purified as specified by the supplier. Sequence data were assembled and analyzed with PC GENE program (Intelligenetics).
Northern blot analysis RNA of various rat tissues was extracted by the acid guanidinium thiocyanate-phenol-chloroform (AGPC) method (23) . Total RNA, 5 ng per lane, was applied to formaline-agarose gel, separated by electrophoresis, blotted onto nylon membrane and hybridized as described previously (5) . A fragment near the 5'-end of the coding region (A in Fig. 2 ) was excised from plasmid pill, purified by gel electrophoresis, and labeled by the random priming method for use as a probe.
Methylation interference analysis of /3-gal-MTBPl fusion protein /3-Galactosidase-MIBP1 fusion protein was expressed using an E.coli clone harboring X3a-21 (Fig. 2) . IPTG-induced bacterial cells were collected and suspended in a solution containing 25mM HEPES-KOH, pH 7.6, 40mM KC1, O.lmM EDTA, 10% glycerol, lmM DTT and O.lmM PMSF (18) . Cells were disrupted by sonication, and centrifuged to collect the supernatant. This crude extract was further purified by precipitation with a 33% saturation of ammonium sulfate. The pellet was dissolved, dialyzed against the suspending solution, and used for analysis.
A probe, an 89-bp fragment of nucleotides 491 to 579 in rat c-myc intron 1, was prepared by PCR using labeled primers as described above. Competitor fragments were also made by PCR using unlabeled primers. Binding reactions and gel electrophoresis were carried out as described for the assay of nuclear extract. Methylation interference analysis was performed as previously described (24) .
RESULTS

Protein-binding sites in c-myc intron 1
We have searched for possible protein-binding sites in the exon 1-intron 1 region of rat c-myc by gel shift and DNase footprinting experiments using rat liver nuclear extract. Several sites were identified by these analyses. One of which, a gel shift assay of a 123-bp region in the 5'-portion of c-myc intron 1 is shown in Figure 1 . This region included sequence elements which are suggested to regulate c-myc expression in mouse or human cells (14, 15) . The gel shift assay revealed at least 7 distinct bands, suggesting the formation of specific complexes between the probe and nuclear proteins of rat liver. Many of the bands disappeared with competition from the same sequence, but not with the unrelated sequence (Fig. lb) . Thus, these complex formations were sequence-specific.
DNase footprinting analysis revealed that distinct regions within this DNA fragment were protected by nuclear proteins (Fig. lc) . Prominent protection was observed at 522 to 535 on the upper (non-coding) strand and at 518 to 545 on the lower (coding) strand. Several hypersensitive sites were also observed both at protected regions and at positions distal to them, which suggested that there were more than two protein-binding sites on this fragment. Methylation interference analysis suggested that the protected region shown in Figure lb could be divided into two sub-regions (518-524, 525-545), each of which accepting a distinct protein to form complexes with different mobilities in gel shift analysis (data not shown).
Cloning of MIBP1 cDNA
Analyses of protein binding to the 5'-portion of intron 1 using the nuclear extract suggested that there is one definite binding site near nucleotides 510 to 530. Therefore, we screened a Xgtl 1 rat liver cDNA expression library by the southwestern method using a concatemer of this intron region as a probe, following the procedures of Vinson et al. (21) . A single cDNA clone, X3a-21, which carried a 2.4-kb insert, was obtained by screening 2x 10 6 phages. Nucleotide sequence determination of this clone revealed a small open reading frame (ORF, 237 amino acids) which had two C2H2 zinc finger motifs located side by side, at the 5'-terminal side of the insert. We referred the gene for this ORF as MIBP1. However, there were several reasons why this clone was apparently chimeric. 1. There were three £coRI sites widiin the insert, and a stop codon was found just after the second £coRI site. 2. Northern blotting revealed mRNAs of different sizes when fragments of the 5'-or 3'-side of the second EcoRl site were used as probes.
We then tried to obtain a non-chimeric, full-length cDNA by hybridization screening. For this purpose, a rat brain cDNA library was used because preliminary Northern blot analysis indicated a high level of MBPl mRNA expression in the brain. Probes C and D (Fig. 2) , which were located outside the zinc finger motifs, were used for plaque hybridization. Fifteen positive clones were identified by this screening. The length and sequences (300-400 bases) of both ends of the insert of each clone were determined. The entire sequence of the longest clone, pdl, was then determined using internal primers, some of which were •535
-•518
-^522
•545
Upper Lower synthesized according to the end-sequences of each clone. A long ORF was found, which continued to the 5'-end of pdl, suggesting that this reading frame extended further upstream. Therefore, we re-screened the same cDNA library using probe B, which was located at the 5'-end of pdl (Fig. 2) . Twenty-two clones were obtained, and each clone was assembled as described above. The pill clone carried the longest insert and extended to the 5'-end. Clone pl28 covered the 3'-end including poly(A) signal and a poly(A) stretch. Thus, a total of 37 clones which constituted a contig of 9.8 kb were obtained (Fig. 2) .
Nucleotide sequence of MIBPl cDNA and protein
The entire nucleotide sequence of MIBPl cDNA was obtained as a composite of sequences of pdl, pi 11 and other clones. The entire region covered by the pdl and pill plasmids was sequenced on both strands. Figure 3 shows the amino acid sequences of MTBP1 protein (nucleotide sequence deposited to DDBJ, accession no. D37951). We reasoned that the initiation codon was at nucleotides 767 -769, because an in-frame stop codon was found 24 bp upstream from this initiation codon and the sequence around this ATG agreed with Kozak's rule (25) . The termination codon of this ORF was found at nucleotides 8075-8077. The putative MIBPl protein consisted of 2437 amino acids and its expected molecular weight was about 267 kd.
The MIBPl protein has two zinc finger cluster regions in the N-terminus (from codons 191 to 241) and in the C-terminus (from codons 1792 to 1842) of the protein, each cluster containing two C2H2 zinc finger motifs. A nuclear localization signal and the acidic region were found at codons 935-941 and downstream of the second zinc finger cluster, respectively. Several serine/threonine-rich regions were also found scattered throughout this cDNA.
Homology
The homology of MIBPl to other sequences was examined against GenBank, EMBL and SWISSPROT databases using the PC-GENE program. AGIE-BP1 (rat angiotensinogen geneinducible enhancer-binding protein 1, ref. 26) and AT-BP1 (rat a 1 -antitrypsin promoter binding protein 1, ref. 27) were almost identical to the C-terminal region of MIBPl, and are likely to be partial clones of MIBPl cDNA. The AGIE-BP1 sequence corresponded to the region from 5332 to 9106 of MIBPl cDNA. The AT-BP1 clone was shorter than AGIE-BP1.
In addition, the MIBPl sequence was highly homologous to human MBP-2/MV-EP2 (MHC binding protein-2/human immunodeficiency virus type 1-enhancer binding protein 2) (28, 29) . Rat MIBPl and human MBP-2/HIV-EP2 were 86% and 93% similar in nucleotide sequence and amino acid sequence, respectively, when aligned by the GAP program from UWGCG amino acid sequences of rat MIBP1 and human MBP-2/HIV- (30) . Therefore, MIBP1 is most likely the rat counterpart of EP2. Zinc finger motifs of MIBP1 were exactly the same as those human MBP-2/HIV-EP2. Figure 3 shows (28), the second ATG of MBP-2/HTV-EP2 might be the actual initiation codon. The fact that the nucleotide sequence near the second ATG agreed with Kozak's sequence supports this conclusion. MIBP1 also showed a 50 % similarity in amino acid sequence to human PRDII-BF1 (Interferon /3 promoter binding protein; also known as MBP-1/HTV-EPl) (31) . The two widely separated zinc finger cluster regions in these two proteins were highly homologous. All four zinc finger motifs were similar between rat MIBP1 and human PRDE-BF1, with 85-100 % identity. The nuclear-localization signal and the acidic region were similar. Both proteins also contained serine/threonine-rich regions. Therefore, the MIBP1 protein (MBP-2/HTV-EP2 protein in human) and the PRDH-BFl/MBP-l/HIV-EPl protein belong to the two-handed zinc finger protein family.
MB8P1 mRNA expression
Expression of MIBP1 mRNA in various tissues was examined by Northern blot analysis. As shown in Figure 4 , MEBP1 mRNA was detected as a single band near 10kb. The same single band was also observed when a much longer fragment (from position 646 to 8887) was used as a probe (data not shown). The amount of MTBP1 mRNA was very low in the liver, but high in the brain. In other tissues, e.g. spleen, kidney and muscle, the expression was moderate. No significant change in the level of MBPl mRNA was observed in regenerating liver (data not shown).
DNA binding of MIBP1 protein
We next examined the binding specificity of MIBP1 protein to DNA by gel shift analysis using the X3a-21 clone. A protein, E. coli jS-galactosidase at the N-terminus, fused to 271 amino acids of the second zinc finger cluster near the C-terminal region of MIBP1 (corresponding to codon 1735-2005), appended by Cterminal 5 amino acids of unknown origin, is expected to be expressed under the control of the lac promoter-operator. By gel shift analysis, sequence-specific activity was detected in the cell extract of E.coli in which the /3-galactosidase-MIBPl fusion protein was induced (Fig. 5a, bands A and B) . These bands were absent when cell extract of E.coli carrying Xgtl 1 was used in the assay (data not shown). The exact nucleotide residues involved in the binding were determined by methylation interference analysis. As shown in Figure 5b , the G residues which interfered with the binding upon methylation were identical in bands A and B. It is unclear why the same complex showed two different bands. In conclusion, the MIBP1 protein could bind to the GGGTAGGCC sequence of intron 1. This sequence coincided with that protected in the DNase I footprinting experiments using liver nuclear extract.
DISCUSSION
We obtained cDNA which carried the entire coding region of the c-myc intron binding protein 1 (MIBP1). This 9.8 kb cDNA covered most of the MIBP1 mRNA sequence, based on the size of the message (10 kb) in Northern blotting analysis. The MIBP1 protein is composed of 2437 amino acids and its expected molecular weight is 267 kd. It has a nuclear localization signal and two widely separated zinc finger domains. Each zinc finger domain carries two C2H2-type zinc finger motifs.
Zajac-Kaye and Levens have shown that the protein MIF binds to a specific region of the human c-myc intron where mutations are frequent in Burkitt lymphoma (15) . The location of this binding site apparently overlaps with the binding site of MIBP1 reported here. However, MIBP1 is most likely distinct from MIF, since MIBP1 is much larger (267 kd) than MTF (138 kd), and recognizes a different sequence. This same site in human c-myc seems to be the binding site for MDBP, a protein ubiquitously found in mammalian nuclei which binds to a 14mer sequence, sometimes methylation-dependently (32) . Again, this protein is distinct from MTBP1 because it has a different recognition sequence.
By searching databases, we found that part of the sequence (the C-terminal one-third of MIBP1) has been reported as AGIE-BP1 or AT-BP1, both of rat origin. AGIE-BP1 has been isolated as a binding factor of the acute-phase response element of angiotensinogen gene, which binds to a NFxB-like binding sequence (26) . AT-BP1 has been isolated as a negative regulator for the promoter of a r antitrypsin gene (27) . The MIBP1 gene is thought to be the rat counterpart of the human MBP-2/HTV-EP2 gene, since the amino acid sequences of the zinc finger motif match exactly, and overall the amino acid sequences are highly conserved (28, 29) . The primary structure of the MIBP1 protein is also similar to that of the PRDH-BF1/ MBP-1/ HIV-EP1 protein, which also has two zinc finger domains, an acidic domain, a nuclear localization signal and a Ser/Thr-rich structure (31) . The two C-terminal zinc finger motifs of MIBP1 were 100% (21/21) and 86% (20/23) identical to those of PRDH-BF1/MBP-1/HIV-EP1.
We also demonstrated that a bacterially synthesized fusion protein which carries the C-terminal zinc finger domain of MEBP1 is able to bind sequence-specifically to a motif (GGGTAGGCC) which is found in intron 1 of rat c-myc. The C-terminal zinc finger clusters of AT-BP1, AGIE-BP1, MBP2 and PRDII-BF1 have been shown to bind to NF*B-like motifs. Particularly strong bindings of these proteins to the MHC-1 promoter motif (GGGG-ATTCCCQ have been reported (26) (27) (28) 31) . Considering all of these results, we can conclude that proteins in this family can bind to the GGGN( 4 _ 5) CC sequence as a minimal requirement. In the case of PRDH-BF1, the binding specificity of the Nterminal zinc finger cluster is the same as that of the C-terminal (31) . The binding activity of the N-terminal zinc fingers of MTBP1 has not yet been examined, since expression of this portion of the protein in E.coli has been unsuccessful to date.
The GGGN 4 CC motif is also found at a similar position in the 5'-region of intron 1 of human c-myc, suggesting that MTBP1 is important in the regulation of c-myc regardless of the species. Both AGIE-BP1 and human MBP-2 suppress transcription of the corresponding targets, i.e., angiotensinogen gene and MHC class I genes, respectively (26, 28) . In view of these findings, MIBP1 may also serve as a negative regulator of c-myc, possibly by competing with NFxB-like factor(s) in the binding to the target sequence. The level of MIBP1 mRNA is high in the brain or muscle, but low in normal liver, while both tissues consist of non-dividing cells and show low c-myc expression. Therefore, there is no simple correlation between the MIBP1 mRNA level and c-myc expression. Perhaps, post-translational modification plays an important role in the function of MIBP1. There are also other possible explanations. Liver cells have the capacity to acutely express c-myc. mRNA immediately after exposure to growth stimuli, as in the case of regenerating liver after partial hepatectomy (5). Brain and muscle cells are inert with respect to growth, and remain quiescent for their entire life. Thus, MIBP1 is not a quickly responding transcriptional regulator of c-myc. Instead, it may maintain the quiescent state of the cell as a longterm regulator of c-myc. Moderate expression of MIBP1 mRNA in the spleen or kidney may be explained by the heterogeneous cell population in these organs. Now that a cDNA clone for MIBP1 is available, it will be possible to analyze whether and how MIBP1 is involved in the regulation of c-myc.
